Skip to content
The Policy VaultThe Policy Vault

Xtandi — Medica

Prostate Cancer – Metastatic, Castration-Sensitive

Initial criteria

  • age ≥ 18 years
  • Xtandi is used concurrently with a gonadotropin-releasing hormone (GnRH) analog OR patient has had a bilateral orchiectomy

Approval duration

1 year